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A novel influenza A (H1N1) virus spread widely in 2009 and emerged as a global
health problem.
1 Although most cases were self-limiting, H1N1 influenza spread
more rapidly than seasonal influenza
2 in 2009 and fatalities occurred in many
countries.
3 During a pandemic, appropriate and prompt diagnosis are critical for
successful treatment and prevention of transmission.
4 Although several laboratory
tests, including real-time reverse transcriptase-polymerase chain reaction (RT-
PCR), are known to be confirmatory tests for novel influenza A (H1N1),
5 clinical
judgment plays a major role in the timely identification of influenza, and labora-
tory tests are not always available during an influenza outbreak.
6,7 Several
organizations have documented their own clinical diagnostic criteria,
8 and these
criteria vary with regard to sensitivity and predictive values for laboratory confir-
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Purpose: Pandemic influenza A (H1N1) virus has spread rapidly and prompt
diagnosis is needed for successful treatment and prevention of transmission. We
investigated clinical predictors, validated the use of previous criteria with labora-
tory tests, and evaluated the clinical criteria for H1N1 infection in the Korean
population. Materials and Methods: We analyzed clinical and laboratory evalua-
tion data from outpatient clinics at Severance Hospital in Seoul, Korea between
November 11 and December 5, 2009. Results: This analysis included a total of
828 patients. Of these, 372 (44.9%) patients were confirmed with H1N1 infection
by real-time reverse transcriptase-polymerase chain reaction (RT-PCR). The most
common and predictive symptom was cough (90.3%, OR 8.87, 95% CI 5.89-
13.38) and about 40% of H1N1-positive patients were afebrile. The best predictive
model of H1N1 infection was cough plus fever or myalgia. The sensitivities, speci-
ficities, positive predictive values, and negative predictive values of our suggested
criteria were 73.9%, 69.5%, 66.4%, and 76.6%, respectively. Conclusion: Cough
was the most common independent symptom in patients with laboratory-con-
firmed H1N1 infection, and while not perfect, the combination of cough plus fever
or myalgia is suggested as clinical diagnostic criteria. Health care providers in
Korea should suspect a cough without fever to be an early symptom of H1N1
infection.  
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med influenza.
9 However, most studies have validated the
use of clinical diagnostic criteria only for seasonal infl-
uenza infection,
6,10 and to the best of our knowledge, have
never been evaluated for influenza A (H1N1). This study
was conducted to evaluate the best clinical predictors for
influenza A (H1N1) infection and to compare different
clinical diagnostic criteria for influenza A (H1N1) with
laboratory diagnostic tests. 
Data collection
This study was approved by the Severance Hospital Ethics
Committee. Clinical and laboratory evaluations were
analyzed from all patients who were admitted to the flu
center [sentinel surveillance outpatient clinic for influenza
A (H1N1) infection] at Severance Hospital. The study
period was from November 11 to December 5, 2009. Indivi-
duals older than 18 years of age with clinical evidence of
acute respiratory symptoms over a duration of less than 7
days were included in this study. Acute respiratory symp-
toms were defined as self-reported influenza-like symp-
toms including chills/feverishness, cough, sore throat,
headache, rhinorrhea, and/or myalgia, with or without a
documented fever.
11 We also included afebrile individuals
(< 37.8˚C) who had been taking antipyretics in the previ-
ous 12 hours. Fever was defined as a body temperature
above 37.8˚C
The analysis excluded individuals with a history of con-
tact with a confirmed influenza A (H1N1) patient without
any acute respiratory symptoms. We also excluded indivi-
duals who had not been confirmed by RT-PCR and indivi-
duals who had been taking antiviral medication (Fig. 1).
Medical records were analyzed for demographic data,
history of contact with influenza A (H1N1) within 7 days,
antiviral medication history, and pre-existing medical con-
ditions including pregnancy. Clinical symptoms and lifest-
yle behaviors such as cigarette smoking, alcohol consump-
tion, and physical activity were also recorded. Body mass
index (BMI) was calculated as weight (kg)/height (m
2).
We analyzed several clinical diagnostic criteria of H1N1
influenza. The Centers for Disease Control and Prevention
(CDC), in US
12 and Korea,
13 defined the clinical diagnostic
criteria as the presence of fever (greater than 37.8˚C or pre-
vious medication with antipyretics) plus one or more of the
following: rhinorrhea, nasal congestion, sore throat or cough.
The World Health Organization (WHO)
14 defined the clini-
cal diagnostic criteria as the sudden onset of fever (> 38˚C)
and cough or sore throat. Influenza like illness (ILI) criteria
is defined by the presence of fever plus two of the following
four symptoms: cough, sore throat, myalgia, and headache.
10
Laboratory assessment
Specimens were collected using nasopharyngeal swabs by
trained physicians. An influenza A (H1N1)-positive case
was defined as a positive result on real-time RT-PCR using
the Lightcycler 480 (Roche, Mannheim, Germany).
15
Conversely, a negative result on RT-PCR was defined as
influenza A (H1N1)-negative. 
Statistical analysis
Continuous variables are expressed as mean ± standard
deviation or medians (with interquartile ranges), and cate-
gorical variables are expressed as percentages. Demogra-
phic and clinical characteristics were compared between
influenza A (H1N1)-positive cases and influenza A (H1N1)-
negative cases using the independent t-test for continuous
variables and the Chi-square test for categorical variables.
The most predictive clinical variables of an illness attribu-
table to influenza A (H1N1) were determined with forward
stepwise logistic regression models. Sensitivity, specifi-
city, positive predictive value (PPV), negative predictive
value (NPV), and area under the curve (AUC) were calcul-
ated to identify the best clinical diagnostic criteria (sug-
gested criteria) of influenza A (H1N1) infection. We also
MATERIALS AND METHODS
Fig. 1. Study diagram for influenza A (H1N1) clinical criteria comparisons and
suggestions. Clinical and laboratory evaluations were analyzed from all patients
who were admitted to the flu center at Severance Hospital. The study period
was from November 11 to December 5, 2009. Acute respiratory symptoms were
defined as self-reported influenza-like symptoms including chills/feverishness,
cough, sore throat, headache, rhinorrhea, and/or myalgia, with or without a
documented fever. RT-PCR, reverse transcriptase-polymerase chain reaction. 
All patients
(n = 1,242)
135 were excluded
- Age < 18 yrs (n = 80)
- Acute respiratory symptoms
duration 7 days (n = 55)
262 were excluded
- No RT-PCR exam for H1N1
(n = 193)
- Taking antiviral medication
(n = 69)
17 were excluded
- H1N1 exposure history    
without any actue 
respiratory symptoms
(n = 17) 
Positive RT-PCR exam for
H1N1 (n = 372) 
Negative RT-PCR exam for
H1N1 (n = 456) 
n = 1,107
n = 845
Final inclusion
(n = 828)compared sensitivity, specificity, PPV, NPV, AUC of the
influenza like illness (ILI) criteria,
7 the Korea CDC criteria,
13
and the WHO criteria
14 with our suggested criteria. All
analyses were conducted using SAS statistical software,
version 9.0 (SAS Institute Inc., Cary, NC, USA). All statis-
tical tests were two-sided, and statistical significance was
defined as p< 0.05.
Demographic and clinical characteristics
A total of 828 patients were included in the analysis, and
372 (44.9%) patients were confirmed to have influenza A
(H1N1) infection by real-time RT-PCR. The median age
of all patients was 32 years old (18-81 years old), and
younger patients were more susceptible than the elderly
[influenza A (H1N1)-positive: 31.6 ± 10.72 years vs. nega-
tive: 36.3 ± 13.04 years, p< 0.001]. BMI was not significan-
tly different between the two groups [influenza A (H1N1)-
positive: 22.6 ± 3.74 kg/m
2 vs. negative: 22.4 ± 3.19 kg/m
2,
p = 0.442]. Influenza A (H1N1) was more frequently dia-
gnosed in women than in men (p = 0.013), and 38.2% of
patients with a confirmed infection had underlying con-
ditions [asthma, 8 (2.2%); chronic pulmonary disease, 4
(1.1%); coronary heart disease, 7 (1.9%); hypertension, 15
(4.1%); DM, 5 (1.4%); thyroid disease, 6 (1.6%); chronic
renal failure, 3 (0.8%); cancer, 11 (3.0%); immune deficie-
ncy disease, 4 (1.1%); cerebrovascular disease, 1 (0.3%);
chronic liver disease, 2 (0.5%); pregnancy 11 (3.0%)] (Table
1). The most frequently reported symptom in the influenza
A (H1N1)-positive group was cough (336, 90.3% of pati-
ents), followed by sore throat (246, 66.1% of patients), and
headache (246, 66.1% of patients). A total of 139 (37.4%)
influenza A (H1N1)-positive patients did not have a fever
or history of antipyretic use. Cough, myalgia, fever (tem-
perature greater than 37.8˚C or antipyretic use within 12
hours before visit), and rhinorrhea were more frequent in
the influenza A (H1N1)-positive group (Fig. 2). The mean
duration of the influenza A (H1N1)-positive illness was
2.1 days. 
Comparison of current clinical diagnostic criteria and 
our suggested criteria 
Stepwise logistic regression showed that cough, myalgia,
and fever (≥ 37.8˚C or the use of antipyretics within 12
hours before visit) were the only factors significantly asso-
ciated with a positive PCR test for influenza A (H1N1). The
best predictive symptom of influenza A (H1N1) infection
was cough. When a history of antipyretics use was not
Clinical Diagnostic Criteria for H1N1 Infection
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Table 1. Demographic Characteristics of 828 Patients Admitted to the Flu Center at Severance Hospital with 
Acute Respiratory Symptoms (November 11 - December 5, 2009)
All
Influenza A  Influenza A 
Characteristic (H1N1)-positive (H1N1)-negative pvalue*
n = 828 (%) n = 372 (%) n = 456 (%)
Age (yrs) < 0.001
18 - 29 344 (41.6) 191 (23.1) 153 (18.5)
30 - 39 297 (35.9) 114 (13.8) 183 (22.1)
40 - 49 89 (10.7) 37 (4.5) 52 (6.3)
50 - 59 47 (5.7) 21 (2.5) 26 (3.1)
≥60 51 (6.1) 9 (1.1) 42 (5.0)
Male 332 (40.1) 167 (44.9) 165 (36.2) 0.013
Alcohol drinker 232 (28.6) 108 (46.6) 124 (53.4) 0.680
Smoker 187 (23.0) 82 (43.9) 105 (56.1) 0.720
Regular exercise 182 (22.4) 78 (42.9) 104 (57.1) 0.514
Underlying condition
� 170 (20.5) 65 (38.2) 105 (61.8) 0.060
Influenza A (H1N1) 379 (46.1) 158 (41.7) 221 (58.3) 0.089
contact history
An alcohol drinker was defined as a person with current alcohol intake more than once a week and a smoker was defined as a current 
cigarette smoker. Regular exercise was defined as exercise or physical work for more than 30 minutes three times a week.
RT-PCR, reverse transcriptase-polymerase chain reaction. 
*Influenza A (H1N1)-positive was defined by a positive result on real-time RT-PCR. Conversely, a negative result on RT-PCR was defined as
influenza A (H1N1)-negative. p values between influenza A (H1N1)-positive and negative were calculated with the t-test, Wilcoxon’s rank
sum test (for continuous variables) or χ 2-test, and Fisher exact test (for categorical variables).
�Underlying conditions: asthma, chronic pulmonary disease, coronary heart disease, Hypertension, Diabetes Mellitus, thyroid disease,
chronic renal failure, cancer, immune deficiency disease, cerebrovascular disease, chronic liver disease or pregnancy.
RESULTSincluded in the model, there were no statistically signifi-
cant differences (data not shown) (Table 2).
The Korean CDC criteria for 2009 pandemic influenza
A (H1N1) were defined by the presence of fever (greater
than 37.8˚C or previous medication with antipyretics) plus
one or more of the following: rhinorrhea or nasal conges-
tion, sore throat, and cough. However, about 40% of the
influenza A (H1N1)-positive patients in this study were
afebrile and only 55.4% fulfilled the clinical criteria of the
CDC. In order to identify a more appropriate clinical cri-
teria, we examined sensitivity, specificity, PPV, and NPV
in combination with cough, fever, myalgia, and rhinorrhea
(Table 3). The sensitivity for cough was 90.3%, but the
specificity and PPV were relatively lower than others in
combination (specificity 47.3%, PPV 58.3%). Considering
sensitivity and PPV together, cough plus fever or myalgia
was the best predictive model for influenza A (H1N1) in-
fection (sensitivity 73.9%, PPV 66.4%). More than 80% of
patients with influenza A (H1N1) met these suggested
criteria, and the sensitivity of these suggested criteria (sen-
sitivity 73.9%) was higher than the Korea CDC criteria,
WHO criteria, and ILI criteria (Table 4).
Since early April 2009, the unique genetic and antigenic
features of influenza A (H1N1) have resulted in a more
rapid spread than is typical of seasonal influenza,
16 and the
epidemiologic profile of H1N1 has varied considerably
depending on the country and continent being examined.
17
During major outbreaks, early and accurate diagnosis of
influenza has the ability to ensure prompt and appropriate
treatment and can ultimately decrease the economic and
public health burden. Several different diagnostic criteria
have been used worldwide for surveillance purposes, but
Choon Ok Kim, et al.
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Table 2. Clinical Predictors of Influenza A (H1N1) Infection by Multivariate Stepwise Logistic Regression 
Analysis
Influenza A (H1N1)  Influenza 
Variables confirmed case like illness OR 95% CI pvalue
(n = 372) (n = 456)
Cough 336 (90.3%) 240 (52.6%) 8.87 5.89 - 13.38 < 0.001
Myalgia 210 (56.5%) 185 (40.6%) 2.18 1.58 - 3.02 < 0.001
Fever* 233 (62.6%) 199 (43.6%) 1.58 1.23 - 2.02 < 0.001
Rhinorrhea 372 (44.9%) 456 (55.1%) 1.06 0.77 - 1.46 0.727
Variables included in the stepwise model: age, sex, fever, cough, sore throat, myalgia, headache, rhinorrhea, and gastrointestinal symptoms 
(nausea, vomiting, diarrhea).
OR, odds ratio; CI, confidence interval.
*Body temperature ≥37.8˚C or the use of an antipyretic within 12 hours before visit.
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Fig. 2. Clinical symptoms and signs of influenza A (H1N1)-positive cases and influenza A (H1N1)-negative cases. Influenza A (H1N1)-positive was
defined as a positive result on real-time RT-PCR. Conversely, a negative result on RT-PCR was defined as influenza A (H1N1)-negative. Cough,
myalgia, fever (greater than 37.8˚C or antipyretic use), and rhinorrhea are more frequent in the influenza A (H1N1)-positive group. *p < 0.05,
calculated by the χ 2-test and Fisher exact test (for categorical variables). RT-PCR, reverse transcriptase-polymerase chain reaction. 
DISCUSSIONthe sensitivity and positive predictive value of such criteria
vary among studies.
7 In addition, there are few data available
to assess the diagnostic criteria associated with pandemic
influenza A (H1N1) infection. 
In Korea, the Korean CDC recommends that antiviral
medication be considered for patients with an acute febrile
respiratory illness (fever: ≥ 37.8˚C or the use of antipyretics
within 12 hours before visit, plus one or more of the follow-
ing: rhinorrhea or nasal congestion, sore throat, and cough)
for the 2009 pandemic influenza A (H1N1). According to
our data, diagnostic criteria that focus on fever are inappro-
priate and may miss about 40% of all influenza infections,
because many of the patients in our sample had afebrile
influenza A (H1N1) infections. The CDC, WHO, and ILI
criteria were specific enough to differentiate suspected
cases but were not sensitive enough to detect all cases.
When there is a pending influenza A (H1N1) pandemic,
the use of clinical diagnostic criteria with high sensitivity is
Clinical Diagnostic Criteria for H1N1 Infection
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Table 4. Validation of Current Diagnostic Criteria for Influenza A (H1N1) and Comparison with our Suggested 
Criteria
Variables CDC criteria WHO criteria ILI criteria Suggested criteria
Influenza A (H1N1) 175 (55.4) 98 (77.2) 147 (72.4) 302 (81.2)
positive case (%)
OR (95% CI) 
Crude 1.97 (1.48 - 2.62)  5.33 (3.43 - 8.28) 4.74 (3.34 - 6.72) 6.47 (4.76 - 8.78)
Adjusted
� 1.93 (1.45 - 2.58) 4.78 (3.05 - 7.47) 4.36 (3.06 - 6.21) 6.26 (4.59 - 8.54)
Sensitivity (%) 47.0 26.7 40.1 73.9
Specificity (%) 69.1 93.6 87.6 69.5
PPV (%) 55.4 77.2 72.4 66.4
NPV (%) 61.5 61.2 64.3 76.6 
Adjusted AUC* 0.651 0.679 0.702 0.765
The CDC criteria are the presence of fever (> 37.8˚C  or previous medication with antipyretics) plus one or more of the following: rhinorrhea, 
nasal congestion, sore throat, or cough. The WHO criteria are the sudden onset of fever (> 38˚C) and cough or sore throat. The ILI criteria are
the presence of fever (≥37.8˚C) plus two of the following four symptoms: cough, sore throat, myalgia, and headache. Our suggested criteria
are the presence of cough plus fever or myalgia. 
OR, odds ratio; CI, confidence interval; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the curve; ILI, influenza
like illness.
*Age, sex adjusted OR, AUC.
Table 3.Sensitivity, Specificity, Positive Predictive Predictive Value (PPV), and Negative Predictive Value 
(NPV) of Suggested Clinical Criteria of Influenza A (H1N1)
Suggested criteria Sensitivity (%) Specificity (%) PPV NPV Adjusted AUC
�
Cough 90.3 47.3 58.3 85.7 0.751
Fever* 62.6 56.4 53.9 64.9 0.657
Myalgia 56.5 59.3 56.3 65.9 0.650
Rhinorrhea 48.1 59.4 49.2 58.4 0.538
Cough + fever 57.5 76.1 66.3 68.7 0.717
Cough + myalgia 51.3 83.3 71.5 67.7 0.744
Cough + rhinorrhea 43.5 74.1 57.9 61.7 0.652
Fever + rhinorrhea 30.1 83.6 59.9 59.4 0.648
Myalgia + rhinorrhea 29.6 86.0 63.2 59.9 0.656
Cough + fever or myalgia 73.9 69.5 66.4 76.6 0.765
Cough + fever or rhinorrhea 72.8 61.6 60.8 73.6 0.724
Fever + cough or myalgia 59.9 63.2 57.0 65.9 0.675
Fever + cough or rhinorrhea 59.7 71.1 62.7 68.3 0.707
Myalgia + cough or fever 53.8 70.4 59.7 65.1 0.691
Rhinorrhea + cough or fever 45.7 69.1 54.7 60.9 0.644
AUC, area under the curve.
*Body temperature  ≥37.8˚C or the use of an antipyretic within 12 hours before visit.
�Age, sex adjusted AUC.Choon Ok Kim, et al.
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important for early detection and isolation of suspected
individuals.
15
While fever was a common symptom in previous studies,
2
the most frequent symptom in our study was cough (90.3%).
Moreover, the most predictive model of influenza A (H1N1)
infection was cough plus fever or myalgia. The sensitivity
of our suggested criteria was 73.9%, the specificity was
69.5%, the PPV was 66.4%, the NPV was 76.6% and the
age and sex adjusted AUC was 0.765. Screening patients
with our criteria for ILI would only have missed 19% of
cases of pandemic influenza A (H1N1).
We did not analyze other subtypes of influenza viruses,
nor did we analyze nonviral pathogens with the ability to
cause acute respiratory illness.
7 Therefore, these criteria may
only be valid for future H1N1 pandemics and may not be
relevant to pandemics with other influenza strains and res-
piratory viruses. The small sample size and the absence of
children from the sample are also limitations of the current
study. A much larger patient sample that includes children
is required to more accurately represent the characteristics
of influenza A (H1N1) infection. 
In summary, cough was the best independent indicator
in laboratory-confirmed influenza A (H1N1), and while not
perfect, a combination of cough plus fever or myalgia is
suggested as diagnostic criteria. According to our data, this
suggested set of criteria demonstrates better sensitivity than
of the conventional criteria used to diagnose H1N1. Health
care providers in Korea should suspect cough without fever
to be early symptoms of influenza A (H1N1) infection. 
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